Tofacitinib in Adult Patients With Moderate to Severe Ulcerative Colitis
NCT04424303
·
clinicaltrials.gov ↗
COMPLETED
Status
152
Enrollment
INDUSTRY
Sponsor class
Conditions
Ulcerative Colitis
Interventions
DRUG:
Tofacitinib
Sponsor
Pfizer